CONVERTIBLE NOTE PURCHASE AGREEMENTConvertible Note Purchase Agreement • March 22nd, 2013 • Nile Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Convertible Note Purchase Agreement (the “Agreement”) is made and entered into as of March 15, 2013 by and among Nile Therapeutics, Inc., a Delaware corporation (the “Company”), and the individuals and/or entities listed on Exhibit A attached hereto (each, a “Purchaser,” collectively, the “Purchasers”).
March 21, 2013 Daron Evans [ADDRESS] Dear Daron:Letter Agreement • March 22nd, 2013 • Nile Therapeutics, Inc. • Pharmaceutical preparations
This letter agreement (this “Agreement”) is intended to confirm our recent discussions concerning amending the terms of your employment with Nile Therapeutics, Inc. ( “Nile” or the “Company”), as follows:
SECURITY AGREEMENTSecurity Agreement • March 22nd, 2013 • Nile Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SECURITY AGREEMENT (this “Agreement”) is made as of March 15, 2013, among Nile Therapeutics, Inc., a Delaware corporation (the “Company”), and the creditors identified in Attachment A hereto, as the same may be supplemented or amended from time to time (collectively, the “Creditors,” and each individually, a “Creditor”), which includes all purchasers of convertible promissory notes sold by the Company pursuant to that certain Convertible Note Purchase Agreement dated March 15, 2013 (the “Purchase Agreement”).
ContractNile Therapeutics, Inc. • March 22nd, 2013 • Pharmaceutical preparations
